Chemed Reports Q1 Results, Boosts Share Buyback Authorization, and Secures New $450M Credit Facility

summarizeSummary

Chemed Corp. reported Q1 2026 results, including a slight increase in adjusted EPS, and announced a significant increase in its share repurchase authorization, a new $450 million revolving credit facility, and a 20% dividend hike.

check_boxKey Events

• Q1 2026 Financial Performance

  Reported Q1 2026 revenue of $657.5 million, a 1.6% increase year-over-year, with adjusted diluted EPS rising to $5.65, a 0.35% increase from $5.63 in Q1 2025.

• Increased Share Repurchase Authorization

  The Board authorized an additional $300 million for stock repurchases in February 2026, with $229.6 million remaining under the program. This follows $197.7 million in repurchases during Q1 2026.

• New $450M Revolving Credit Facility

  Secured a new five-year $450 million revolving credit facility, including $100 million for letters of credit, with an expansion feature for an additional $250 million, significantly boosting liquidity.

• Dividend Per Share Increase

  Increased cash dividends per share by 20% to $0.60 in Q1 2026, up from $0.50 in Q1 2025.

auto_awesomeAnalysis

This quarterly report provides comprehensive details following the preliminary earnings release. While GAAP diluted EPS saw a minor decline, adjusted diluted EPS increased slightly. The most significant market-moving information includes the Board's authorization of an additional $300 million for share repurchases, bringing the remaining authorization to $229.6 million, signaling strong confidence in future value. Furthermore, the company secured a new five-year $450 million revolving credit facility with an expansion feature for an additional $250 million, substantially enhancing its financial flexibility and liquidity. The 20% increase in cash dividends per share also reflects management's positive outlook and commitment to shareholder returns.